| Nutex Health, Inc. (NUTX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | |||||||
| Fiscal Period | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | Q4-FY2013 | |||||||
| Price to Sales | 1.02x | .59x | .87x | .52x | .35x | .33x | .10x | .28x | .49x | .57x | 1.40x | 3.35x | |||||||||||||||||||||||||||||||||||||
| Price to Book | 3.15x | 1.84x | 2.92x | 1.84x | 1.27x | 1.60x | .46x | 1.14x | 1.96x | 1.47x | 2.99x | 7.10x | |||||||||||||||||||||||||||||||||||||
| Price to Earnings | 8.29x | 4.82x | 12.19x | 4.42x | 3.22x | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||
| Price to Unlevered FCF | 5.66x | 3.29x | 8.23x | 4.67x | 7.92x | 4.97x | 1.90x | - | - | 1,439.76x | - | 187.26x | |||||||||||||||||||||||||||||||||||||
| Debt to Asset Ratio | .55x | .60x | .66x | .71x | .82x | .81x | .80x | .80x | .78x | .75x | .75x | .72x | .51x | .13x | 7.68x | .23x | .55x | .72x | .72x | .70x | .57x | .50x | 4.33x | .44x | .37x | .33x | .29x | .11x | .09x | 3.88x | 12.49x | .81x | .84x | .82x | .80x | .86x | 1.25x | 1.71x | 1.02x | .59x | .46x | .48x | |||||||
| Current Ratio | 3.20x | 2.43x | 2.05x | 1.90x | 1.77x | 1.59x | 1.68x | 1.56x | 1.34x | 1.60x | 1.85x | 1.79x | 4.09x | .60x | .14x | .18x | .10x | .06x | .27x | .29x | .05x | .06x | .09x | .08x | .28x | .25x | .25x | 1.26x | 1.10x | .73x | .51x | .97x | 1.62x | 2.10x | 2.04x | ||||||||||||||